The world of fitness and health is often portrayed as a gender-neutral space, but a recent study has shed light on a concerning gap in healthcare that disproportionately affects women. This article delves into the hidden risks and challenges faced by women in the fitness industry, particularly those who use performance and image-enhancing drugs (PIEDs), and the urgent need for a more inclusive and informed approach to their health.
The Gendered Health Gap
In the fitness industry, there exists an information vacuum regarding the use of steroids, peptides, and stimulants among women. This lack of knowledge has created a gendered health gap, with women facing unique risks and challenges that are often overlooked or misunderstood.
The use of PIEDs by women carries distinct health implications, including virilizing effects, hormonal disruptions, and changes to menstrual and reproductive health. These risks are not merely theoretical; they are real and have a significant impact on women's overall well-being.
Stigma and Silence
One of the key findings of the University of Queensland study is the perception that men are more open about their peptide use compared to women. Women, on the other hand, often remain silent due to the stigma surrounding these substances. This stigma not only discourages women from seeking help but also contributes to a lack of awareness and understanding among health professionals.
Personally, I find it fascinating how social media wellness trends have inadvertently contributed to this issue. Influencers promoting peptides online have likely influenced a wider audience, including women outside the traditional bodybuilding world, without fully considering the potential consequences.
Dismissed Experiences
The research highlights a concerning trend: even the most recent clinical guidelines on PIEDs are primarily focused on research conducted on men. This means that women's experiences and the unique ways their bodies respond to these substances are often overlooked or dismissed.
"Women's experiences seem to just be dismissed," says Hannah Schuurs, one of the report's authors. This statement is a powerful reminder of the systemic bias that exists in healthcare, where women's health concerns are sometimes treated as an afterthought.
Shifting Responsibility
The study also reveals that women who use PIEDs often face systemic barriers and knowledge gaps. They are proactive in managing their health risks, yet the responsibility for harm reduction and care coordination is shifted onto them, rather than being shared by clinicians.
This raises a deeper question about the role of healthcare professionals. Shouldn't they be the ones taking the lead in discussing peptide use without judgment and stigma? After all, it is their duty to provide informed care and guidance, especially in such a sensitive and complex area of health.
Breaking the Stigma
The interviews with nine women who had used PIEDs from Australia, the US, and Canada paint a stark picture of the stigma they face from doctors. One Australian bodybuilder in her 30s had to take matters into her own hands, requesting routine blood tests to monitor her health. Another competitive bodybuilder felt judged by her doctor, who failed to request hormone profiles due to her participation in competitions.
These experiences highlight the urgent need for a cultural shift in healthcare. Health professionals must be encouraged to build better rapport with their patients, especially those who use PIEDs. Open and non-judgmental conversations are essential to ensuring women receive the care and support they deserve.
Conclusion
The use of peptides and other performance-enhancing substances by women in the fitness industry is a complex issue that demands our attention. It reveals a gendered health gap, a lack of understanding, and a need for more inclusive healthcare practices. By addressing these challenges, we can ensure that women receive the informed care and support they need to navigate the risks associated with PIEDs.
